Samsung BioLogics threatens legal action after accounting probe sparks stock slide
Samsung BioLogics has threatened to sue the Korean government after news of an accounting probe wiped $6bn off its value.
Archives for May 3, 2018
Janssen strengthens immunotherapy capabilities with BeneVir acquisition
Janssen Biotech has entered into a definitive agreement to acquire BeneVir Biopharm, a deal which looks to advance Janssen’s immunotherapy platform and capabilities.